Assessing the Value-Adding Impact of Diagnostic-Type Tests on Drug Development and Marketing

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.12, Iss.5, 2008-01, pp. : 331-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessing the diagnostic accuracy of a sequence of tests

By Thompson M.L.

Biostatistics, Vol. 4, Iss. 3, 2003-07 ,pp. : 341-351

Oxford University Press

Access to resources Recommend Favorite

Drug Development: From Concept to Marketing!

Nephron Clin Pract, Vol. 113, Iss. 3, 2009-08 ,pp. : c125-c131

Karger

Access to resources Recommend Favorite

Negative predictive value of drug provocation tests in children

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 25, Iss. 7, 2014-11 ,pp. : 685-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

ASSESSING VALUE, BUDGET IMPACT, AND AFFORDABILITY IN ASIA

International Journal of Technology Assessment in Health Care, Vol. 33, Iss. 2, 2017-05 ,pp. : 315-322

Cambridge University Press

Access to resources Recommend Favorite

Market access challenges in the EU for high medical value diagnostic tests

By Miller Iain Ashton-Chess Joanna Spolders Herman Fert Vincent Ferrara Joseph Kroll Werner Askaa Jon Larcier Patrick Terry Patrick F Bruinvels Anne Huriez Alain

Personalized Medicine, Vol. 8, Iss. 2, 2011-03 ,pp. : 137-148

Future Medicine

Access to resources Recommend Favorite